Post Marketing Surveillance to Monitor the Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix When Administered According to the Prescribing Information to Indian Infants.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RIX 4414 (Primary)
Indications Rotavirus infections
Focus Adverse reactions
Acronyms ROTA-071 PMS
Sponsors GlaxoSmithKline; GSK

Most Recent Events

15 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
31 Aug 2010 Status changed from completed to active, no longer recruiting as reported by Clinical Trials Registry - India.
04 May 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight